1,038 results found

The 100% FDI in pharma sector through automatic approval route in new projects and investments in the existing companies only through the approval route has prompted several acquisitions and not given the desired result.

This move not only makes clinical trials for academic research on drugs more cost effective and efficient, but also promotes innovation in terms of treatment of critical maladies like AIDS, cancer, etc.

In an information release by Press Information Bureau on 14th May 2016, Ministry of AYUSH Government of India and the World Health organization (WHO) have signed an historic Project Collaboration Agreement (PCA) for cooperation on promoting the quality, safety and effectiveness of service provision in traditional and complementary medicine.

The Ministry of Health and Family Welfare, Government of India vide Gazette notification nos. S.0.4379(E) to S.0.4706(E) dated 07.09.2018 has prohibited 328 Fixed Dose Combinations (FDCs) for manufacture, sale or distribution with immediate effect ..

The officials at the Health Ministry have recently said that they are planning to bring in a clear provision in the law to promote generic drugs.

On April 26, 2026, Sun Pharmaceutical Industries Limited (“Sun Pharma”) and Organon & Co. (“Organon”) announced an agreement for Sun Pharma to acquire all outstanding shares of Organon...

India-Pakistan showdowns, whether in sports or political relations, are always newsworthy. This time there was a change in the battleground and the reason for the showdown was the claim over ‘BASMATI' rice as...

A long battle over the monopoly control of Hepatitis C medicine was concluded by China's State Intellectual Property Office (SIPO).

La Renon then approached the Madras High Court in an appeal against the IPAB order in the form of a writ petition.

One of the major influencers in the Indian Patent context has been the TRIPs agreement.

The recommendations have faced a lot of backlash from multinational pharmaceutical companies.

No NOC for Pharmaceutical Exports to Developed Countries: The Central Drugs Standard Control Organisation (CDSCO) has relaxed the drug regulatory clearance for the pharmaceutical exporters of India.

The proposed formula will prove to be a great aid in computing the quantum of compensation in the cases of SAEs of deaths occurring during clinical trials.

As one of the country's largest industries, the Indian Food Processing Industry is expected to bolster the Indian economy.

April 6, 2014 was a red letter day for the Indian pharmaceutical industry as Sun Pharmaceutical Industries Limited ("Sun Pharma") and Ranbaxy Laboratories Limited ("Ranbaxy") announced that they had entered into definitive documents for merger of Ranbaxy with Sun Pharma ("Transaction").

To strengthen the technical evaluation process that supports regulatory decisions and to bring formal structure to the functioning of Subject Expert Committees (SECs)...

The Food Safety and Standards Authority of India (FSSAI) has proposed draft amendments to the Food Safety and Standards (Labelling and Display) Regulations, 2020.